Allied Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	992.46	978.33	618.49	679.75	757.39	703.48
Short-Term Investments	50.95	8.91	106.28	113.25	386.82	255.87
Cash & Short-Term Investments	1,043	987.24	724.77	793	1,144	959.35
Cash Growth	-	36.21%	-8.60%	-30.69%	19.27%	26.25%
Accounts Receivable	143.99	131.24	109.85	118.54	105.08	117.62
Other Receivables	4.98	1.75	3.6	5.39	4.63	0.72
Receivables	148.97	132.99	113.46	123.92	109.71	118.34
Inventory	506.09	527.54	601.48	596.47	508.09	485.24
Other Current Assets	15.59	15.33	17.17	21.54	23.52	22.58
Total Current Assets	1,714	1,663	1,457	1,535	1,786	1,586
Property, Plant & Equipment	551.2	567.87	594	623.49	625.99	650.39
Long-Term Investments	-	-	0.05	0.73	2.59	5.81
Long-Term Deferred Tax Assets	21.61	16.67	17.37	12.55	15.44	13.43
Other Long-Term Assets	10.5	9.22	10.62	11.31	11.84	5.41
Total Assets	2,297	2,257	2,079	2,183	2,441	2,261
Accounts Payable	28.84	26.66	27.65	38.64	47.21	27.73
Accrued Expenses	54.83	40.13	35.5	43.78	30.61	-
Short-Term Debt	930	870	700	720	1,110	845
Current Portion of Long-Term Debt	18.31	18.31	18.31	18.31	125.99	18.31
Current Portion of Leases	4.29	5.36	5.1	5.49	5.79	6.09
Current Income Taxes Payable	5.59	10.88	16.85	27.46	1.64	5.35
Current Unearned Revenue	3.47	2.6	4.64	1.26	1.59	0.71
Other Current Liabilities	18.4	22.31	20.65	39.84	23.91	68.19
Total Current Liabilities	1,064	996.25	828.69	894.77	1,347	971.37
Long-Term Debt	39.03	52.76	71.07	89.38	-	125.99
Long-Term Leases	4.56	7.74	0.95	3.89	1.03	4.49
Pension & Post-Retirement Benefits	-	-	5.92	3.94	9.64	11.42
Long-Term Deferred Tax Liabilities	4.62	4.57	3.49	7.43	2.47	2.01
Total Liabilities	1,112	1,061	910.12	999.4	1,360	1,115
Common Stock	962.43	960.24	957.85	953.85	953.51	951.52
Additional Paid-In Capital	12.13	9.65	7.74	5.67	5.19	3.89
Retained Earnings	216.07	231.31	209.28	229.88	127.6	189.98
Comprehensive Income & Other	-5.21	-5.67	-6.08	-5.79	-4.79	-0.1
Shareholders' Equity	1,185	1,196	1,169	1,184	1,082	1,145
Total Liabilities & Equity	2,297	2,257	2,079	2,183	2,441	2,261
Total Debt	996.19	954.17	795.43	837.07	1,243	999.87
Net Cash (Debt)	47.21	33.07	-70.66	-44.06	-98.6	-40.52
Net Cash Per Share	0.49	0.34	-0.74	-0.46	-1.03	-0.43
Filing Date Shares Outstanding	96.24	96.02	95.78	95.38	95.35	95.15
Total Common Shares Outstanding	96.24	96.02	95.78	95.38	95.35	95.15
Working Capital	650.33	666.85	628.19	640.17	438.79	614.16
Book Value Per Share	12.32	12.45	12.20	12.41	11.34	12.04
Tangible Book Value	1,185	1,196	1,169	1,184	1,082	1,145
Tangible Book Value Per Share	12.32	12.45	12.20	12.41	11.34	12.04
Land	210.22	210.22	210.22	210.22	210.22	210.22
Buildings	290.39	288.9	286.98	258.26	263.3	262.8
Machinery	979.51	965.22	950.97	915.59	858.72	841.1
Construction In Progress	14.45	6.07	6.96	42.43	56.22	46.38

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.